MktsMarkets

RxSight, Inc.
NASDAQ: RXSTKey statistics
RXST News
Stories mentioning RXST from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 30,893 | 32,607 | 30,340 | 33,637 | 37,895 | 40,214 | 35,314 | 34,887 |
| Cost of Goods Sold | 7,395 | 7,344 | 6,113 | 8,447 | 9,566 | 11,426 | 10,094 | 10,637 |
| Gross Profit | 23,498 | 25,263 | 24,227 | 25,190 | 28,329 | 28,788 | 25,220 | 24,250 |
| Operating Expenses | ||||||||
| Research & Development | 9,472 | 8,905 | 9,060 | 10,217 | 10,367 | 9,207 | 8,838 | 8,291 |
| Sales General & Admin | 31,855 | 27,694 | 27,345 | 28,976 | 28,636 | 28,210 | 25,608 | 24,292 |
| Total Operating Expenses | 41,327 | 36,599 | 36,405 | 39,193 | 39,003 | 37,417 | 34,446 | 32,583 |
| Operating Income (Loss) | (17,829) | (11,336) | (12,178) | (14,003) | (10,674) | (8,629) | (9,226) | (8,333) |
| Interest Income | ||||||||
| Interest Expense | 3.00 | 4.00 | 4.00 | 5.00 | 6.00 | 4.00 | 5.00 | 6.00 |
| Other Expense | ||||||||
| Pretax Income | (15,878) | (9,146) | (9,806) | (11,754) | (8,172) | (5,926) | (6,325) | (6,063) |
| Tax Provision | 6.00 | 6.00 | 10.00 | 32.00 | 18.00 | 12.00 | 13.00 | 16.00 |
| Net Income (Loss) | (15,884) | (9,152) | (9,816) | (11,786) | (8,190) | (5,938) | (6,338) | (6,079) |
| Earnings Per Share (Basic) | (0.38) | (0.22) | (0.24) | (0.29) | (0.20) | (0.15) | (0.16) | (0.16) |
| Earnings Per Share (Diluted) | (0.38) | (0.22) | (0.24) | (0.29) | (0.20) | (0.15) | (0.16) | (0.16) |
| Weighted Average Shares Outstanding (Basic) | 41,306 | 40,851 | 40,965 | 40,744 | 40,510 | 38,868 | 39,789 | 38,456 |
| Weighted Average Shares Outstanding (Diluted) | 41,306 | 40,851 | 40,965 | 40,744 | 40,510 | 38,868 | 39,789 | 38,456 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About RXST
RxSight, Inc. (NASDAQ: RXST) is a stock listed on the Nasdaq Stock Market under the ticker symbol RXST. It last traded at $5.01 (Nov 18, 2026, 4:00 PM ET), up 3.7% on the day. That gives RxSight a market capitalisation of $210.1M.
Over the past 52 weeks RXST has traded between $4.11 and $13.22.
Revenue for the quarter ended Mar 31, 2026 was $30.9M; a net loss of $15.9M. Revenue was down 18.5% from $37.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $30.9M | -$15.9M | -51.4% |
| Dec 31, 2025 | $32.6M | -$9.2M | -28.1% |
| Sep 30, 2025 | $30.3M | -$9.8M | -32.4% |
| Jun 30, 2025 | $33.6M | -$11.8M | -35.0% |
From RxSight’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…